AbbVie

Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background
Biotech

Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3

The phase 3 data keep Atea barreling toward a second readout for its shorter, simpler treatment regimen.
Nick Paul Taylor Jul 28, 2026 9:08am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

AbbVie inks $10.9B Apogee buyout to bag eczema prospect

Jun 22, 2026 7:59am
White arrow on a road pointing to the rising sun

Avalo’s phase 2 win fuels AbbVie chase despite placebo headwind

May 6, 2026 6:00am
Kestrel perched on a branch

AbbVie dips into boiling RAS waters with $1.45B biobucks deal

Apr 28, 2026 10:01am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

AbbVie inks $745M deal with China’s Haisco for two pain assets

Apr 13, 2026 9:48am
MA combine

Alzheimer's-focused Korsana uses Cyclerion merger to go public

Apr 1, 2026 9:54am